Oxybutynin chloride 5 MG Oral Tablet

INDICATIONS AND USAGE Oxybutynin Chloride Tablets USP are indicated for the relief of symptoms of bladder instability associated with voiding in patients with uninhibited neurogenic or reflex neurogenic bladder (i.e., urgency, frequency, urinary leakage, urge incontinence, dysuria).

Pliva Inc.

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] off label use` `[3] fatigue` `[4] toxicity to various agents` `[5] headache` `[6] nausea` `[7] completed suicide` `[8] pain` `[9] diarrhoea` `[10] drug abuse`

10 years ago

ROUND BLUE PLIVA 456

HOW SUPPLIED

OXYBUTYNIN CHLORIDE Tablets USP are available as follows: 5 mg – Very pale blue, round, biconvex, scored tablets. debossed with PLIVA 456 on one side and scored on the other side . Available in bottles of 100 (NDC 50111-456-01), 500 (NDC 50111-456-02), and 1000 (NDC 50111-456-03) tablets. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). Store at 20º to 25ºC (68º to 77ºF) [See USP Controlled Room Temperature]. KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.

More pills like ROUND PLIVA 456

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site

Oxybutynin chloride 5 MG Oral Tablet

FDA Reported Adverse Reactions [1] drug ineffective [2] off label use [3] fatigue [4] toxicity to various agents [5] headache [6] nausea [7] completed suicide [8] pain [9] diarrhoea [10] drug abuse

ROUND BLUE PLIVA 456

More pills like ROUND PLIVA 456

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] off label use` `[3] fatigue` `[4] toxicity to various agents` `[5] headache` `[6] nausea` `[7] completed suicide` `[8] pain` `[9] diarrhoea` `[10] drug abuse`